When we compared the extent of BC-LI-0186-dependent inhibition of S6K phosphorylation between the wild-type and S974A mutant-expressing cells, the mutant-expressing cells showed higher resistance to the compound than those expressing the wild-type LRS (Fig. 4c). This evidence concerns the gene RPS6KB1 and breast cancer.